Answer quick questions
Complete a short online consultation. No waiting rooms, no appointments, and it only takes a few minutes.
Wegovy® Injectable Pen
FDA-approved GLP-1 treatment for weight management[1]
- Lose an average of 20.7%† of your body weight. Individual results vary.[2]
- Once-weekly self-injection pen
- Helps reduce food noise and increase feelings of fullness
- Shown to cut heart disease risk[3]
After completing a short health questionnaire, one of our licensed providers will review your case. If you’re eligible, they’ll recommend the most appropriate dose for you.
Dr. Abhishek Patel
Board Certified Physician
*The pricing provided is an estimate only and is not final. Actual costs may vary, and the pharmacy will confirm the final price at the time of fulfillment. Prescription required following an online consultation with a licensed US provider.
Get started
Kickstart your weight loss journey
Fill out a quick consultation to check your eligibility and see prices
Lose an average of 20.7% of your weight with Wegovy®
Licensed US providers
Fulfilled by Novo Nordisk®
FDA-approved
Wegovy® information
Wegovy contains semaglutide, a GLP-1 receptor agonist. It mimics a natural hormone released after eating, which signals fullness to your brain. It reduces appetite and calorie intake, leading to gradual, sustained weight loss alongside a healthy diet and regular movement.
Both contain semaglutide and are FDA-approved for the same purpose. The injection is taken once a week, on the same day each week, with or without food. The oral pill is taken once a day, first thing in the morning, on an empty stomach and at least 30 minutes before eating or drinking. Your provider can recommend the right format based on your profile and preferences, subject to approval.
Many patients begin to notice weight loss within the first 4–8 weeks. Clinical results were measured over 64–72 weeks. Wegovy is part of a long-term treatment program, and the best results come from consistent use alongside positive lifestyle changes and regular provider check-ins.
The most commonly reported side effects are nausea, vomiting, diarrhea, constipation and stomach pain. These are most common when starting treatment or stepping up your dose, and typically lessen over time. See Important Safety Information for the full list.
Yes, subject to eligibility and following an online consultation with a licensed US provider. Treatment is fulfilled directly by Novo Nordisk.
Adults who meet the BMI threshold may be eligible. Complete your consultation to find out. A licensed provider makes the final clinical determination.
Wegovy is FDA-approved for weight management. Ozempic is FDA-approved for type 2 diabetes. ZipHealth prescribes Wegovy only.
Wegovy is designed as a long-term treatment for weight management. Your provider will be able to discuss your recommended treatment duration at your consultation and during check-ins.
Your provider may recommend an alternative branded medication like Zepbound® or Foundayo™. You won’t be charged until a suitable treatment is confirmed.
15,000+ verified customer reviews
“So fast and easy”
The process is so fast and easy and I can’t stress enough how important that is especially when you’re not feeling well
“Wonderful customer service”
Product came earlier than expected and was packed perfectly. Will continue to do business. I'm a very happy new customer
“Changed my life forever”
ZipHealth has changed my life forever! I almost lost hope. I highly highly recommend ZipHealth if you have a hard time getting it going.
“You can trust this company”
Thank you Ziphealth for the fast service and great product! Order came 2 days later and was exactly what I wanted. You can trust this company to fulfill your medical needs.
“ZipHealth rules”
A few basic questions about your health and medications you may be taking and that’s it! Very easy to navigate, find what is right for you, and there you go!
“As easy as possible”
Excellent service, very prompt physician feedback/response to any initial query(s), and fast shipping! No better service to be found for these products and you have the option to pay as you go/need the meds, rather than commit to an ongoing refill/reshipment. I liked that! ZipHealth makes the entire process as easy as possible.
“So much easier than driving”
Thank you, the medicine works great for me I appreciate the fast service and reliable. It's so much easier than driving to a doctor's office thank you.
“Easy online ordering”
Great service. Wonderful product... works great. I can not thank you guys enough.
“You have to try this company”
They are the real deal. They are as advertised. Better pricing than anyone and delivery was fast and effective. No more standing in long lines at pharmacy and paying ridiculous prices.
“Fast and easy ordering process”
This is my 3rd order with ZipHealth. Both of my previous orders arrived quickly and I have zero doubt that I will have this order in hand by next week. I will be ordering from them again.
“This saves hours a month”
Extremely helpful and very up to date with a modern lifestyle. Talk to a professional quickly and get treatment quickly. For someone always on the go this saves hours a month in doctors offices.
“Always fast and convenient!”
Arrives timely and the savings are greatly appreciated!
Wegovy® facts
Treatment type
GLP-1 receptor agonist
Average weight loss
20.7% (STEP UP trial, 7.2mg)†
Active ingredient
Semaglutide
Available strengths
0.25mg · 0.5mg · 1.0mg · 1.7mg · 2.4mg
Administration
Once-weekly subcutaneous injection
How it works
2
Choose your treatment
A licensed provider reviews your answers and, if appropriate, prescribes your medication. Most decisions are made within 24 hours.
3
Get it delivered fast
Your Wegovy ships directly from Novo Nordisk to your door. Your provider adjusts your dose as your treatment progresses.
Prescription issued at licensed US provider’s discretion following an online consultation.
References
1. Important Safety Information
2. STEP UP, Based on a 72 week study of adults with obesity using Wegovy (semaglutide 2.4mg). Individual results may vary.
3. SELECT study; Wegovy shown to cut the risk of major cardiovascular events by 20% in adults with obesity and heart disease. Individual results vary.
